Li JuMing, Zhu Yan, Wei YongZhong
Orthopedics. 2014 May;37(5):e512-6. doi: 10.3928/01477447-20140430-66.
Malignant transformation of conventional giant cell tumor of bone is rare and usually occurs with irradiation. This article describes a case of malignant transformation of a giant cell tumor 15 years after initial curettage and bone graft. A 35-year-old man was admitted to the hospital with a recurrent giant cell tumor of the distal femur. On presentation, the patient reported the insidious onset of a dull aching pain in the distal part of the left thigh 4 months prior to admission. Radiographs revealed a destructive lesion in the left distal femur. Needle biopsy revealed recurrence of giant cell tumor with suspected malignant transformation. The patient underwent en bloc resection of the distal femur with adequately wide margins and reconstruction of the knee joint with a prosthesis. Pathological findings showed malignant transformation of a giant cell tumor to high-grade spindle cell sarcoma. Immunohistochemistry showed diffuse and strong p53 expression. A diagnosis of secondary fibrosarcoma was made after discussion. Unfortunately, the tumor proved to be highly resistant to the chemotherapy, and the patient died of multiple lung metastases 14 months after the diagnosis of malignant transformation. What has to be stressed in this case is that any late recurrence must be approached considering the possibility of a secondary induced primary tumor. Because of the rarity of this disease, the effective therapeutic strategy for fibrosarcoma secondary to giant cell tumor is lacking. In addition, identification of the p53 mutation may help in diagnosing cases of potential malignant transformation of giant cell tumor.
骨传统型巨细胞瘤的恶性转化较为罕见,通常发生于放疗后。本文描述了1例在初次刮除术及骨移植15年后发生巨细胞瘤恶性转化的病例。一名35岁男性因复发性股骨远端巨细胞瘤入院。就诊时,患者自述入院前4个月左大腿远端隐匿性出现钝痛。X线片显示左股骨远端有一破坏性病变。针吸活检显示巨细胞瘤复发并疑似恶性转化。患者接受了股骨远端整块切除,切缘足够宽,并采用假体重建膝关节。病理结果显示巨细胞瘤已恶变为高级别梭形细胞肉瘤。免疫组化显示p53弥漫性强表达。经讨论后诊断为继发性纤维肉瘤。不幸的是,肿瘤对化疗高度耐药,患者在恶性转化诊断后14个月死于多发肺转移。该病例必须强调的是,对于任何晚期复发,都必须考虑继发性原发性肿瘤的可能性。由于这种疾病罕见,缺乏针对巨细胞瘤继发性纤维肉瘤的有效治疗策略。此外,p53突变的鉴定可能有助于诊断巨细胞瘤潜在恶性转化的病例。